BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35146482)

  • 1. A Series of BRAF- and NRAS-Driven Murine Melanoma Cell Lines with Inducible Gene Modulation Capabilities.
    Bok I; Angarita A; Douglass SM; Weeraratna AT; Karreth FA
    JID Innov; 2022 Mar; 2(2):100076. PubMed ID: 35146482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Versatile ES Cell-Based Melanoma Mouse Modeling Platform.
    Bok I; Vera O; Xu X; Jasani N; Nakamura K; Reff J; Nenci A; Gonzalez JG; Karreth FA
    Cancer Res; 2020 Feb; 80(4):912-921. PubMed ID: 31744817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible and reversible lentiviral and Recombination Mediated Cassette Exchange (RMCE) systems for controlling gene expression.
    Bersten DC; Sullivan AE; Li D; Bhakti V; Bent SJ; Whitelaw ML
    PLoS One; 2015; 10(3):e0116373. PubMed ID: 25768837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of NRASQ61R and BRAFV600E in human melanoma cells activates senescence and increases susceptibility to cell-mediated cytotoxicity.
    Petti C; Molla A; Vegetti C; Ferrone S; Anichini A; Sensi M
    Cancer Res; 2006 Jul; 66(13):6503-11. PubMed ID: 16818621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification
    Yum SY; Choi W; Kim S; Jang G; Koo O
    Anim Biotechnol; 2023 Dec; 34(9):4730-4735. PubMed ID: 36905152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutually exclusive NRASQ61R and BRAFV600E mutations at the single-cell level in the same human melanoma.
    Sensi M; Nicolini G; Petti C; Bersani I; Lozupone F; Molla A; Vegetti C; Nonaka D; Mortarini R; Parmiani G; Fais S; Anichini A
    Oncogene; 2006 Jun; 25(24):3357-64. PubMed ID: 16462768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid genetic modification of mouse embryonic stem cells by Inducible Cassette Exchange recombination.
    Iacovino M; Roth ME; Kyba M
    Methods Mol Biol; 2014; 1101():339-51. PubMed ID: 24233789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma.
    Burd CE; Liu W; Huynh MV; Waqas MA; Gillahan JE; Clark KS; Fu K; Martin BL; Jeck WR; Souroullas GP; Darr DB; Zedek DC; Miley MJ; Baguley BC; Campbell SL; Sharpless NE
    Cancer Discov; 2014 Dec; 4(12):1418-29. PubMed ID: 25252692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streamlined Human Cell-Based Recombinase-Mediated Cassette Exchange Platform Enables Multigene Expression for the Production of Therapeutic Proteins.
    Shin S; Kim SH; Lee JS; Lee GM
    ACS Synth Biol; 2021 Jul; 10(7):1715-1727. PubMed ID: 34133132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel genetically engineered mouse models for clear cell renal cell carcinoma.
    van der Mijn JC; Laursen KB; Fu L; Khani F; Dow LE; Nowak DG; Chen Q; Gross SS; Nanus DM; Gudas LJ
    Sci Rep; 2023 May; 13(1):8246. PubMed ID: 37217526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual NRASQ61R and BRAFV600E mutation-specific immunohistochemistry completes molecular screening in melanoma samples in a routine practice.
    Uguen A; Guéguen P; Legoupil D; Bouvier S; Costa S; Duigou S; Lemasson G; Ledé F; Sassolas B; Talagas M; Férec C; Le Maréchal C; De Braekeleer M; Marcorelles P
    Hum Pathol; 2015 Nov; 46(11):1582-91. PubMed ID: 26297254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing isogenic inducible cell lines using founder reporter lines and recombinase-mediated cassette exchange.
    Guan B; Magomi T; Wang TL; Shih IeM
    Biotechniques; 2013 Nov; 55(5):233-42. PubMed ID: 24215638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinase-Mediated Cassette Exchange (RMCE)-in Reporter Cell Lines as an Alternative to the Flp-in System.
    Callesen MM; Berthelsen MF; Lund S; Füchtbauer AC; Füchtbauer EM; Jakobsen JE
    PLoS One; 2016; 11(8):e0161471. PubMed ID: 27541869
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Hill KS; Roberts ER; Wang X; Marin E; Park TD; Son S; Ren Y; Fang B; Yoder S; Kim S; Wan L; Sarnaik AA; Koomen JM; Messina JL; Teer JK; Kim Y; Wu J; Chalfant CE; Kim M
    Mol Cancer Res; 2019 Feb; 17(2):583-593. PubMed ID: 30355677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel Bxb1 integrase RMCE system for high fidelity site-specific integration of mAb expression cassette in CHO Cells.
    Inniss MC; Bandara K; Jusiak B; Lu TK; Weiss R; Wroblewska L; Zhang L
    Biotechnol Bioeng; 2017 Aug; 114(8):1837-1846. PubMed ID: 28186334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Integration of Single-Copy Transgenes in Drosophila melanogaster Tissue-Culture Cells Using Recombination-Mediated Cassette Exchange.
    Manivannan SN; Jacobsen TL; Lyon P; Selvaraj B; Halpin P; Simcox A
    Genetics; 2015 Dec; 201(4):1319-28. PubMed ID: 26500255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9-mediated reporter knock-in in mouse haploid embryonic stem cells.
    Kimura Y; Oda M; Nakatani T; Sekita Y; Monfort A; Wutz A; Mochizuki H; Nakano T
    Sci Rep; 2015 Jun; 5():10710. PubMed ID: 26039937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly efficient site-specific transgenesis in cancer cell lines.
    Michael IP; Monetti C; Chiu AC; Zhang P; Baba T; Nishino K; Agha-Mohammadi S; Woltjen K; Sung HK; Nagy A
    Mol Cancer; 2012 Dec; 11():89. PubMed ID: 23231822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A method for specifically targeting two independent genomic integration sites for co-expression of genes in CHO cells.
    Baser B; Spehr J; Büssow K; van den Heuvel J
    Methods; 2016 Feb; 95():3-12. PubMed ID: 26658354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene Editing in Human Induced Pluripotent Stem Cells Using Doxycycline-Inducible CRISPR-Cas9 System.
    Thamodaran V; Rani S; Velayudhan SR
    Methods Mol Biol; 2022; 2454():755-773. PubMed ID: 33830454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.